T. Onoe

4-step, 2-h carboplatin desensitization in Japanese patients with ovarian cancer: a prospective study

S. Morita, Koji Matsumoto, H. Sakai, 2021, International Journal of Clinical Oncology.

4-step 4-h carboplatin desensitization protocol for patients with gynecological malignancies showing platinum hypersensitivity: a retrospective study

M. Tanioka, Y. Kikukawa, S. Negoro, 2015, International Journal of Clinical Oncology.

Immunotherapy for squamous cell carcinoma of the head and neck.

Kaoru Tanaka, T. Ogawa, K. Matsuura, 2020, Japanese journal of clinical oncology.

Safety and Relative Dose Intensity of Dose-dense Doxorubicin and Cyclophosphamide Followed by Dose-dense Paclitaxel

S. Takao, Koji Matsumoto, H. Sakai, 2019, AntiCancer Research.

Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck.

Kaoru Tanaka, T. Akimoto, T. Ogawa, 2020, Japanese journal of clinical oncology.

Induction TPF chemotherapy followed by CRT with fractionated administration of cisplatin in patients with unresectable locally advanced head and neck cancer

T. Akimoto, M. Tahara, Y. Ota, 2019, International Journal of Clinical Oncology.

PARP inhibitors for BRCA wild type ovarian cancer; gene alterations, homologous recombination deficiency and combination therapy.

T. Onda, N. Yaegashi, Koji Matsumoto, 2019, Japanese journal of clinical oncology.

Phase II trial of combination treatment with paclitaxel, carboplatin and cetuximab (PCE) as first-line treatment in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CSPOR-HN02)

T. Yamanaka, K. Muro, A. Homma, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase 1 dose‐escalation study of single‐agent veliparib in Japanese patients with advanced solid tumors

T. Shimoi, M. Yunokawa, K. Yonemori, 2017, Cancer science.

Randomized Phase II Trial Comparing Site-Specific Treatment Based on Gene Expression Profiling With Carboplatin and Paclitaxel for Patients With Cancer of Unknown Primary Site.

H. Mukai, Y. Ohashi, K. Nishio, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical benefit of treatment after trastuzumab emtansine for HER2-positive metastatic breast cancer: a real-world multi-centre cohort study in Japan (WJOG12519B)

A. Shimomura, S. Kurozumi, T. Takano, 2021, Breast Cancer.